prof.dr. G.C.M. Kusters (Ron)

Heerink, J. S., Oudega, R., Gemen, E., Hopstaken, R. , Koffijberg, H. , & Kusters, R. (2023). Are the latest point-of-care D-dimer devices ready for use in general practice? A prospective clinical evaluation of five test systems with a capillary blood feature for suspected venous thromboembolism. Thrombosis Research, 232, 113-122. https://doi.org/10.1016/j.thromres.2023.10.014

Heerink, J. S., Oudega, R., Hopstaken, R. , Koffijberg, H. , & Kusters, R. (2023). Clinical decision rules in primary care: necessary investments for sustainable healthcare. Primary health care research & development, 24, Article e34. https://doi.org/10.1017/S146342362300021X

Heerink, J. S., Nies, J. , Koffijberg, H., Oudega, R. , Kip, M. M. A. , & Kusters, R. (2023). Two point-of-care test-based approaches for the exclusion of deep vein thrombosis in general practice: a cost-effectiveness analysis. BMC Primary Care, 24(1), Article 42. https://doi.org/10.1186/s12875-023-01992-z

Lingervelder, D. , Kip, M. M. A., Wiese, E. D. , Koffijberg, H. , Ijzerman, M. J. , & Kusters, R. (2022). The societal impact of implementing an at-home blood sampling device for chronic care patients: patient preferences and cost impact. BMC health services research, 22(1), Article 1529. https://doi.org/10.1186/s12913-022-08782-w

Kurstjens, S., De Bel, T., van der Horst, A. , Kusters, R., Krabbe, J., & van Balveren, J. (2022). Automated prediction of low ferritin concentrations using a machine learning algorithm. Clinical Chemistry and Laboratory Medicine, 60(12), 1921-1928. https://doi.org/10.1515/cclm-2021-1194

Loots, F. J., Smits, M., Jenniskens, K., van Zanten, A. R. H. , Kusters, R., Verheij, T. J. M., & Hopstaken, R. M. (2022). Added Diagnostic Value of Biomarkers in Patients with Suspected Sepsis: A Prospective Cohort Study in Out-Of-Hours Primary Care. The journal of applied laboratory medicine, 7(5), 1088-1097. https://doi.org/10.1093/jalm/jfac031

van Balveren, J. A., Verboeket-van de Venne, W. P. H. G. , Doggen, C. J. M., Erdem-Eraslan, L. , de Graaf, A. J., Krabbe, J. G., Musson, R. E. A., Oosterhuis, W. P., De Rijke, Y. B., van der Sijs, H., Tintu, A. N., Verheul, R. J., Hoedemakers, R. M. J. , & Kusters, R. (2022). Added value of drug-laboratory test interaction alerts in test result authorisation. Clinical Chemistry and Laboratory Medicine, 60(5), E108-E111. https://doi.org/10.1515/cclm-2022-0077

van Balveren, J. A., Erdem-Eraslan, L., Verboeket-van de Venne, W. P. H. G. , Doggen, C. J. M., Hofland, J., Oosterhuis, W. P., de Rijke, Y. B., Hoedemakers, R. M. J. , & Kusters, R. (2022). Awareness of drug laboratory test interactions is important for prevention of unnecessary additional diagnostics: An example. Clinica Chimica Acta, 530, 99-103. https://doi.org/10.1016/j.cca.2022.03.013

Covid Retro Collaboration, & CAPACITY-COVID consortium (2022). Clinical prediction models for mortality in patients with covid-19: external validation and individual participant data meta-analysis. BMJ, 378, Article e069881. https://doi.org/10.1136/bmj-2021-069881

Heerink, J. S., Péquériaux, N., Oudega, R., de Jong, M. , Koffijberg, H. , & Kusters, R. (2022). Implementation of a care pathway for deep vein thrombosis: What's the benefit? Thrombosis Update, 7, Article 100109. https://doi.org/10.1016/j.tru.2022.100109

Lingervelder, D. (2022). The adoption of point-of-care testing in primary care: Health economic evidence and organisational factors. [PhD Thesis - Research UT, graduation UT, University of Twente]. University of Twente. https://doi.org/10.3990/1.9789036553681

van Balveren, J. A. (2022). Drug laboratory test interactions in clinical practice: Improving laboratory test interpretation by creating awareness. [PhD Thesis - Research UT, graduation UT, University of Twente]. University of Twente. https://doi.org/10.3990/1.9789464194883

Heerink, J. S., Gemen, E., Oudega, R., Geersing, G. J., Hopstaken, R. , & Kusters, R. (2022). Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients. The journal of applied laboratory medicine, 7(2), 444-455. https://doi.org/10.1093/jalm/jfab094

Lingervelder, D. , Koffijberg, H., Emery, J. D., Fennessy, P., Price, C. P., van Marwijk, H., Eide, T. B., Sandberg, S., Cals, J. W. L., Derksen, J. T. M. , Kusters, R. , & IJzerman, M. J. (2022). How to Realize the Benefits of Point-of-Care Testing at the General Practice: A Comparison of Four High-Income Countries. International Journal of Health Policy and Management, 11(10), 2248-2260. https://doi.org/10.34172/ijhpm.2021.143

van Balveren, J. A., Verboeket-van de Venne, W. P. H. G. , Doggen, C. J. M., Erdem-Eraslan, L. , De Graaf, A. J., Krabbe, J. G., Musson, R. E. A., Oosterhuis, W. P., De Rijke, Y. B., Van Der Sijs, H., Tintu, A. N., Verheul, R. J., Hoedemakers, R. M. J. , & Kusters, R. (2021). Real-time monitoring of drug laboratory test interactions: A proof of concept. Clinical Chemistry and Laboratory Medicine, 60(2), 235-242. https://doi.org/10.1515/cclm-2021-0790

Kurstjens, S., Gemen, E., Walk, S., Njo, T., Krabbe, J., Gijzen, K., Elisen, M. G. L. M. , & Kusters, R. (2021). Performance of commercially-available cholesterol self-tests. Annals of Clinical Biochemistry, 58(4), 289-296. https://doi.org/10.1177/0004563221992393

on behalf of the Dutch Society for Clinical Chemistry and Laboratory Medicine and task group ‘SMILE’: Signaling Medication Interactions and Laboratory test Expert system (2021). Clinical usefulness of drug-laboratory test interaction alerts: A multicentre survey. Clinical Chemistry and Laboratory Medicine, 59(7), 1239-1245. https://doi.org/10.1515/cclm-2020-1770

Lingervelder, D. , Koffijberg, H. , Kusters, R. , & IJzerman, M. J. (2021). Health Economic Evidence of Point-of-Care Testing: A Systematic Review. PharmacoEconomics - Open, 5(2), 157-173. https://doi.org/10.1007/s41669-020-00248-1

Kurstjens, S., Van Der Horst, A., Herpers, R., Geerits, M. W. L., Kluiters-De Hingh, Y. C. M., Göttgens, E. L., Blaauw, M. J. T., Thelen, M. H. M., Elisen, M. G. L. M. , & Kusters, R. (2020). Rapid identification of SARS-CoV-2-infected patients at the emergency department using routine testing. Clinical Chemistry and Laboratory Medicine, 58(9), 1587-1593. https://doi.org/10.1515/cclm-2020-0593

Kip, M. M. A., Oonk, M. L. J., Levin, M. D., Schop, A., Bindels, P. J. E. , Kusters, R. , & Koffijberg, H. (2020). Preventing overuse of laboratory diagnostics: a case study into diagnosing anaemia in Dutch general practice. BMC medical informatics and decision making, 20(1), Article 178. https://doi.org/10.1186/s12911-020-01198-8

Heerink, J., Gemen, E., Oudega, R., Hopstaken, R., Geersing, G. J. , & Kusters, R. (2020). Analytical performance and user-friendliness of five novel point-of-care D-dimer assays. Scandinavian Journal of Clinical and Laboratory Investigation, 80(5), 433-440. https://doi.org/10.1080/00365513.2020.1768586

van Balveren, J., Verboeket-Van de Venne, W., Erdem-Eraslan, L., de Graaf, A., Musson, R., Oosterhuis, W., van der Sijs, I., Verheul, R. , Kusters, R., & Hoedemakers, R. (2019). Real-time monitoring of drug-laboratory test interactions with an automated decision support application. Clinica Chimica Acta, 493(Suppl. 1), S531-S532. https://doi.org/10.1016/j.cca.2019.03.1118

Kip, M., Oonk, M. L. J., Levin, M. D. L. , Kusters, G. C. M. , & Koffijberg, E. (2019). More information worse decisions? Evaluating potential overuse of laboratory diagnostics in diagnosing anaemia. Value in health, 22(Suppl. 3), S908-S908. https://doi.org/10.1016/j.jval.2019.09.2665

Lingervelder, D. , Koffijberg, E. , Kusters, G. C. M. , & IJzerman, M. (2019). Business models supporting the integration of point-of-care testing at the general practice: a comparison of England and the Netherlands. Value in health, 22(Suppl. 3), S793-S793. https://doi.org/10.1016/j.jval.2019.09.2090

Lingervelder, D. , Koffijberg, E. , Kusters, G. C. M. , & IJzerman, M. (2019). Insights into the impact of point-of-care testing: a systematic review of health-economic evaluations. Value in health, 22(Suppl. 3), S670-S671. https://doi.org/10.1016/j.jval.2019.09.1423